Cent Eur Neurosurg 2005; 66(2): 75-78
DOI: 10.1055/s-2005-836488
Invited Article

© Georg Thieme Verlag Stuttgart · New York

Ethical Aspects of Use of Fetal/Embryonic Cells in Treatment and Research

Ethische Aspekte des Nutzens fötaler/embryonaler Zellen in Forschung und TherapieH. Watt1
  • 1Linacre Centre for Healthcare Ethics, London, United Kingdom
Further Information

Publication History

Publication Date:
22 April 2005 (online)

Abstract

The use of cells derived from in vitro embryos or aborted human fetuses raises serious moral questions for doctors and researchers. It is not enough to anticipate good from such use: morality is concerned not merely with outcome, but with choices and their impact on character. The human moral subject is the human organism, who has rights and interests from the beginning of his or her existence. Harvesting cells or tissue from an embryo or fetus who is deliberately destroyed - in some cases, by the harvesting itself - is a violation of the rights of the individual concerned. To accept cells or tissue from those who did the harvesting (as opposed to using a much older cell-line) is to give the impression that we condone the harvesting, and indeed the taking of the donor's life. Irrespective of the medical benefits for which we may be hoping, we cannot relieve the suffering of one human individual by exploiting another.

References

  • 1 Anderson F, Glasier A, Ross J, Baird D T. Attitudes of women to fetal tissue research.  J Med Ethics. 1994;  20 36-40
  • 2 Doherty P. Post-Abortion Syndrome. Four Courts Press, Dublin 1995
  • 3 Grisez G, Boyle J, Finnis J. Practical principles, moral truth and ultimate ends.  Am J Jur. 1987;  32 99-151
  • 4 McCullagh P. Brain Dead, Brain Absent, Brain Donors. John Wiley & Sons, Chichester 1993; 148-177
  • 5 Nobin A, Bjorklund A. Topography of the monoamine neuron systems in the human brain as revealed in fetuses.  Acta Physiologica Scandinavia. 1973;  388 (Suppl) 4
  • 6 Oderberg D. Moral Theory: A Non-Consequentialist Approach. Blackwell, Oxford 2000
  • 7 Olson L, Stromberg I, Bygdeman M, Granholm A C, Hoffer B, Freedman R, Seiger A. Human fetal tissues grafted to rodent hosts: structural and functional observations of brain, adrenal and heart tissues in oculo.  Experimental Brain Research. 1987;  67 163-178
  • 8 Ring-Cassidy E, Gentles I. Women's Health after Abortion. De Veber Institute for Bioethics and Social Research, Toronto 2002
  • 9 Scolding N. Cooperation problems in science: use of embryonic/fetal material. In: Watt H (ed). Cooperation, Complicity and Conscience: Problems in healthcare, science, law and public policy. The Linacre Centre, London (in preparation)
  • 10 Watt H. Life and Death in Healthcare Ethics. Routledge, London 2000; 21-23, 47-49
  • 11 Watt H. Life and Death in Healthcare Ethics. Routledge, London 2000; 45-53
  • 12 Watt H. Beyond double effect: Side-effects and bodily harm. In: Oderberg D, Chappell T (eds). Human Values: New Essays on Ethics and Natural Law. Palgrave Macmillan, Houndmills 2004
  • 13 Zolese G, Blacker C VR. The psychological complications of therapeutic abortion.  Br J Psych. 1992;  160 742-749

Dr. Helen Watt, Director 

Linacre Centre for Healthcare Ethics

60 Grove End Road

London NW8 9NH

United Kingdom

Phone: +44/20/78 06 40 88

Fax: +44/20/72 66 54 24

Email: h.watt@linacre.org

    >